2017
DOI: 10.1016/s0140-6736(16)32452-7
|View full text |Cite
|
Sign up to set email alerts
|

A strengthening evidence-base for mass deworming, but questions remain

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2017
2017
2020
2020

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 12 publications
0
3
0
Order By: Relevance
“…Above all, the likelihood of prevalence of helminth infections > 20% in the study sites consistent to other studies pointed out the need for transmission elimination plans including mass deworming. The success may depend upon the increased investment to address the research gaps through the appropriate use of sensitive diagnostic tools to detect persistent infections and polyparasitism apart from the conventional K-K method [29, 30].…”
Section: Discussionmentioning
confidence: 99%
“…Above all, the likelihood of prevalence of helminth infections > 20% in the study sites consistent to other studies pointed out the need for transmission elimination plans including mass deworming. The success may depend upon the increased investment to address the research gaps through the appropriate use of sensitive diagnostic tools to detect persistent infections and polyparasitism apart from the conventional K-K method [29, 30].…”
Section: Discussionmentioning
confidence: 99%
“…Meta-analysis and meta-regression are observational research that depends on the quality of the studies that are included. As previously noted by others [31], the level of evidence for many NTD clinical studies has to be categorized as only “very low, low, or moderate quality”. That said, is has been the chronic underfunding of clinical trials (performed in resource limited settings) that has been an important part of the ‘neglect’ of NTDs.…”
Section: Discussionmentioning
confidence: 99%
“…The perceived quality of individual studies was assessed, but not formally quantified in our analysis because of specific limiting features found in many NTD trials [31]. A summary of study design and quality factors for each included study is presented in supplemental information file S2 Text: ‘Study design and quality features for included studies’.…”
Section: Methodsmentioning
confidence: 99%